Longitudinal research suggests that genetic, lifestyle, and environmental factors enhance one’s risk for developing Alzheimer’s disease and related dementias (ADRD). However, it is not known how an accumulation of such factors impact brain functioning. One barrier to this research is that increased risk for ADRD affects the cerebrovascular system and, therefore, alters the link between neural activity and the fMRI BOLD signal. To better interpret fMRI findings, several steps were taken to adjust fMRI activity thereby reducing such cerebrovascular effects. We hypothesized that as the number of ADRD risk factors increase, brain regions within the medial temporal lobes and the default mode network would exhibit altered brain activity during an episodic memory retrieval task. Middle-aged and older adults (aged 50–74) free of dementia were recruited with varying levels of risk and underwent a neuropsychological battery and fMRI. In the memory task, participants viewed a pair of pictures. In an alternative-forced-choice test, participants viewed a picture cue and had to determine which of four pictures was paired with the cue. Increased dementia risk was positively associated with brain activity in regions of interest within the default mode network, the hippocampus, and the entorhinal cortex during memory retrieval. Whole-brain analyses revealed additional positive associations in prefrontal and occipito-temporal cortices. Risk factors most contributing to these elevated levels of brain activity included hypertension, diabetes, obesity, and cholesterol. We also ruled out confounds due to in-scanner performance and premorbid ability. Cumulative risk might represent early signs of burnout in brain regions underlying episodic memory.
KochanekKD, MurphySL, XuJ, Tejada-VeraB (2016) Deaths: Final data for 2014. Natl Vital Stat Rep65, 1–122.
2.
JackCRJr, KnopmanDS, JagustWJ, PetersenRC, WeinerMW, AisenPS, ShawLM, VemuriP, WisteHJ, WeigandSD, LesnickTG, PankratzVS, DonohueMC, TrojanowskiJQ (2013) Tracking pathophysiological processes in Alzheimer’s disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol12, 207–216.
3.
SperlingRA, AisenPS, BeckettLA, BennettDA, CraftS, FaganAM, IwatsuboT, JackCRJr, KayeJ, MontineTJ, ParkDC, ReimanEM, RoweCC, SiemersE, SternY, YaffeK, CarrilloMC, ThiesB, Morrison-BogoradM, WagsterMV, PhelpsCH (2011) Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 280–292.
4.
McDonoughIM, AllenRS (2018) Biological markers of aging and mental health: A seed and soil model of neurocognitive disorders. Aging Ment Health23, 793–799.
5.
SperlingR, MorminoE, JohnsonK (2014) The evolution of preclinical Alzheimer’s disease: Implications for prevention trials. Neuron84, 608–622.
6.
BraakH, ThalDR, GhebremedhinE, Del TrediciK (2011) Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years. J Neuropathol Exp Neurol70, 960–969.
OhH, MadisonC, BakerS, RabinoviciG, JagustW (2016) Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer’s disease. Brain139, 2275–2289.
9.
BucknerRL, SnyderAZ, ShannonBJ, LaRossaG, SachsR, FotenosAF, ShelineYI, KlunkWE, MathisCA, MorrisJC, MintunMA (2005) Molecular, structural, and functional characterization of Alzheimer’s disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci25, 7709–7717.
BucknerRL, SepulcreJ, TalukdarT, KrienenFM, LiuH, HeddenT, Andrews-HannaJR, SperlingRA, JohnsonKA (2009) Cortical hubs revealed by intrinsic functional connectivity: Mapping, assessment of stability, and relation to Alzheimer’s disease. J Neurosci29, 1860–1873.
12.
JonesDT, KnopmanDS, GunterJL, Graff-RadfordJ, VemuriP, BoeveBF, PetersenRC, WeinerMW, JackCRJr (2016) Cascading network failure across the Alzheimer’s disease spectrum. Brain139, 547–562.
13.
MorminoEC, BrandelMG, MadisonCM, MarksS, BakerSL, JagustWJ (2012) Aβ deposition in aging is associated with increases in brain activation during successful memory encoding. Cereb Cortex22, 1813–1823.
14.
ElmanJA, OhH, MadisonCM, BakerSL, VogelJW, MarksSM, CrowleyS, O’NeilJP, JagustWJ (2014) Neural compensation in older people with brain amyloid-β deposition. Nat Neurosci17, 1316–1318.
15.
HuijbersW, MorminoEC, WigmanSE, WardAM, VanniniP, McLarenDG, BeckerJA, SchultzAP, HeddenT, JohnsonKA, SperlingRA (2014) Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults. J Neurosci34, 5200–5210.
16.
KennedyKM, RodrigueKM, DevousMDSr, HebrankAC, BischofGN, ParkDC (2012) Effects of beta-amyloid accumulation on neural function during encoding across the adult lifespan. Neuroimage62, 1–8.
17.
SperlingRA, LaViolettePS, O’KeefeK, O’BrienJ, RentzDM, PihlajamakiM, MarshallG, HymanBT, SelkoeDJ, HeddenT, BucknerRL, BeckJA, JohnsonKA (2009) Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron63, 178–188.
18.
SperlingR (2011) The potential of functional MRI as a biomarker in early Alzheimer’s disease. Neurobiol Aging32, S37–S43.
19.
SongZ, McDonoughIM, LiuP, LuH, ParkDC (2016) Cortical amyloid burden and age moderate hippocampal activity in cognitively-normal adults. Neuroimage Clin12, 78–84.
20.
FratiglioniL (1993) Epidemiology of Alzheimer’s disease: Issues of etiology and validity. Acta Neurol Scand87, 1–70.
21.
Van DuijnCM, ClaytonD, ChandraV, FratiglioniL, GravesAB, HeymanA, JormAF, KokmenE, KondoK, MortimerJA, RoccaWA, ShalatSL, SoininenH (1991) Familial aggregation of Alzheimer’s disease and related disorders: A collaborative re-analysis of case-control studies. Int J Epidemiol20, S13–S20.
22.
MichaelsonDM (2014) APOE ɛ4: The most prevalent yet understudied risk factor for Alzheimer’s disease. Alzheimers Dement10, 861–868.
23.
FarrowM (2007) Dementia Risk Reduction: What Do Australian’s Know?, Alzheimer’s Australia, Canberra.
24.
DeckersK, van BoxtelMP, SchiepersOJ, de VugtM, Muñoz SánchezJL, AnsteyKJ, BrayneC, DartiguesJF, EngedalK, KivipeltoM, RitchieK, StarrJM, YaffeK, IrvingK, VerheyFR, KohlerS (2015) Target risk factors for dementia prevention: A systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry30, 234–246.
25.
KivipeltoM, NganduT, LaatikainenT, WinbladB, SoininenH, TuomilehtoJ (2006) Risk score for the prediction of dementia risk in 20 years among middle aged people: A longitudinal, population-based study. Lancet Neurol5, 735–741.
26.
HeymanA, FillenbaumG, ProsnitzB, RaifordK, BurchettB, ClarkC (1991) Estimated prevalence of dementia among elderly black and white community residents. Arch Neurol48, 594–598.
27.
PerkinsP, AnnegersJF, DoodyRS, CookeN, AdayL, VernonSW (1997) Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. Neurology49, 44–50.
28.
TangMX, CrossP, AndrewsH, JacobsDM, SmallS, BellK, MerchantC, LantigueR, CostaR, SternY, MayeuxR (2001) Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology56, 49–56.
29.
BarnesDE, CovinskyKE, WhitmerRA, KullerLH, LopezOL, YaffeK (2009) Predicting risk of dementia in older adults: The late-life dementia risk index. Neurology73, 173–179.
30.
ExaltoLG, BiesselsGJ, KarterAJ, HuangES, KatonWJ, MinkoffJR, WhitmerRA (2013) Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: A cohort study. Lancet Diabetes Endocrinol1, 183–190.
31.
KaffashianS, DugravotA, ElbazA, ShipleyMJ, SabiaS, KivimäkiM, Singh-ManouxA (2013) Predicting cognitive decline: A dementia risk score vs the Framingham vascular risk scores. Neurology80, 1300–1306.
32.
PodewilsLJ, GuallarE, KullerLH, FriedLP, LopezOL, CarlsonM, LyketsosCG (2005) Physical activity, APOE genotype, and dementia risk: Findings from the Cardiovascular Health Cognition Study. Am J Epidemiol161, 639–651.
33.
HabibM, MakE, GabelS, SuL, WilliamsG, WaldmanA, WellsK, RitchieK, RitchieC, O’BrienJT (2017) Functional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer’s disease. Ageing Res Rev36, 88–104.
34.
BookheimerSY, StrojwasMH, CohenMS, SaundersAM, Pericak-VanceMA, MazziottaJC, SmallGW (2000) Patterns of brain activation in people at risk for Alzheimer’s disease. N Engl J Med343, 450–456.
35.
MaturaS, PrvulovicD, HartmannD, ScheibeM, SepanskiB, ButzM, Oertel-KnöchelV, KnöchelC, KarakayaT, FußerF, HattingenE, PantelJ (2016) Age-related effects of the apolipoprotein E gene on brain function. J Alzheimers Dis52, 317–331.
36.
SinhaN, BergCN, TustisonNJ, ShawA, HillD, YassaMA, GluckMA (2018) APOE ɛ4 status in healthy older African Americans is associated with deficits in pattern separation and hippocampal hyperactivation. Neurobiol Aging69, 221–229.
37.
BraskieMN, SmallGW, BookheimerSY (2010) Vascular health risks and fMRI activation during a memory task in older adults. Neurobiol Aging31, 1532–1542.
38.
ChenY, LiuZ, WangA, ZhangJ, ZhangS, QiD, ChenK, ZhangZ (2016) Dysfunctional organization of default mode network before memory impairments in type 2 diabetes. Psychoneuroendocrinology74, 141–148.
39.
MarderTJ, FloresVL, BoloNR, HoogenboomWS, SimonsonDC, JacobsonAM, FooteSE, ShentonME, SperlingRA, MusenG (2014) Task-induced brain activity patterns in type 2 diabetes: A potential biomarker for cognitive decline. Diabetes63, 3112–3119.
40.
WoodAG, ChenJ, MoranC, PhanT, BeareR, CooperK, LitrasS, SrikanthV (2016) Brain activation during memory encoding in Type 2 diabetes mellitus: A discordant twin pair study. J Diabetes Res2016, 1–10.
41.
BuxtonRB, UludağK, DubowitzDJ, LiuTT (2004) Modeling the hemodynamic response to brain activation. Neuroimage23, S220–S233.
42.
LogothetisNK (2008) What we can do and what we cannot do with fMRI. Nature453, 869–878.
43.
D’EspositoM, DeouellLY, GazzaleyA (2003) Alterations in the BOLD fMRI signal with ageing and disease: A challenge for neuroimaging. Nat Rev Neurosci4, 863–872.
44.
GradyCL, SpringerMV, HongwanishkulD, McIntoshAR, WinocurG (2006) Age-related changes in brain activity across the adult lifespan. J Cogn Neurosci18, 227–241.
45.
MohtasibRS, LumleyG, GoodwinJA, EmsleyHC, SlumingV, ParkesLM (2012) Calibrated fMRI during a cognitive Stroop task reveals reduced metabolic response with increasing age. Neuroimage59, 1143–1151.
46.
HanSD, BangenKJ, BondiMW (2009) Functional magnetic resonance imaging of compensatory neural recruitment in aging and risk for Alzheimer’s disease: Review and recommendations. Dement Geriatr Cogn Disord27, 1–10.
47.
TsvetanovKA, HensonRN, TylerLK, DavisSW, ShaftoMA, TaylorJR, WilliamsN, Cam-CAN, RoweJB (2015) The effect of ageing on f MRI: Correction for the confounding effects of vascular reactivity evaluated by joint f MRI and MEG in 335 adults. Hum Brain Mapp36, 2248–2269.
48.
DaulatzaiMA (2012) Quintessential risk factors: Their role in promoting cognitive dysfunction and Alzheimer’s disease. Neurochem Res37, 2627–2658.
HandwerkerDA, OllingerJM, D’EspositoM (2004) Variation of BOLD hemodynamic responses across subjects and brain regions and their effects on statistical analyses. Neuroimage21, 1639–1651.
51.
HuettelSA, SingermanJD, McCarthyG (2001) The effects of aging upon the hemodynamic response measured by functional MRI. Neuroimage13, 161–175.
52.
MiezinFM, MaccottaL, OllingerJM, PetersenSE, BucknerRL (2000) Characterizing the hemodynamic response: Effects of presentation rate, sampling procedure, and the possibility of ordering brain activity based on relative timing. Neuroimage11, 735–759.
53.
KannurpattiSS, BiswalBB (2008) Detection and scaling of task-induced fMRI-BOLD response using resting state fluctuations. Neuroimage40, 1567–1574.
54.
KannurpattiSS, MotesMA, BiswalBB, RypmaB (2014) Assessment of unconstrained cerebrovascular reactivity marker for large age-range FMRI studies. PloS One9, e88751.
KannurpattiSS, MotesMA, RypmaB, BiswalBB (2011) Increasing measurement accuracy of age-related BOLD signal change: Minimizing vascular contributions by resting-state-fluctuation-of-amplitude scaling. Hum Brain Mapp32, 1125–1140.
57.
de BruijnRF, IkramMA (2014) Cardiovascular risk factors and future risk of Alzheimer’s disease. BMC Med12, 130.
58.
de la TorreJC (2012) Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol2012, 1–15.
59.
TariqSH, TumosaN, ChibnallJT, PerryMH3rd, MorleyJE (2006) Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder—a pilot study. Am J Geriatr Psychiatry14, 900–910.
60.
FolsteinMF, FolsteinSE, McHughPR (1975) “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
61.
WechslerD (1944) The measurement of adult intelligence, Williams and Wilkins, Baltimore.
62.
MaDS, CorrellJ, WittenbrinkB (2015) The Chicago face database: A free stimulus set of faces and norming data. Behav Res Methods4, 1122–1135.
KonkleT, BradyTF, AlvarezGA, OlivaA (2010) Scene memory is more detailed than you think: The role of categories in visual long-term memory. Psychol Sci21, 1551–1556.
65.
SestieriC, TosoniA, MignognaV, McAvoyMP, ShulmanGL, CorbettaM, RomaniGL (2014) Memory accumulation mechanisms in human cortex are independent of motor intentions. J Neurosci34, 6993–7006.
66.
MazaikaPK, WhitfieldS, CooperJC (2005) Detection and repair of transient artifacts in fMRI data. Neuroimage26, S36.
67.
BeckmannCF, SmithSM (2004) Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans Med Imaging23, 137–152.
68.
PowerJD, BarnesKA, SnyderAZ, SchlaggarBL, PetersenSE (2012) Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage59, 2142–2154.
69.
PowerJD, MitraA, LaumannTO, SnyderAZ, SchlaggarBL, PetersenSE (2014) Methods to detect, characterize, and remove motion artifact in resting state fMRI. Neuroimage84, 320–341.
70.
CoxRW (1996) AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res29, 162–173.
DickersonBC, BakkourA, SalatDH, FeczkoE, PachecoJ, GreveDN, GrodsteinF, WrightCI, BlackerD, RosasHD, SperlingRA, AtriA, GrowdonJH, HymanBT, MorrisJC, FischlB, BucknerRL (2008) The cortical signature of Alzheimer’s disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex19, 497–510.
73.
KarlamanglaAS, Miller-MartinezD, LachmanME, TunPA, KoretzBK, SeemanTE (2014) Biological correlates of adult cognition: Midlife in the United States (MIDUS). Neurobiol Aging35, 387–394.
74.
BeatonD, Chin FattCR, AbdiH (2014) An ExPosition of multivariate analysis with the singular value decomposition in R. Comput Stat Data Anal72, 176–189.
75.
SmithSM, FoxPT, MillerKL, GlahnDC, FoxPM, MackayCE, FilippiniN, WatkinsKE, ToroR, LairdAR, BeckmannCF (2009) Correspondence of the brain’s functional architecture during activation and rest. Proc Natl Acad Sci U S A106, 13040–13045.
76.
KennedyKM, RodrigueKM, BischofGN, HebrankAC, Reuter-LorenzPA, ParkDC (2015) Age trajectories of functional activation under conditions of low and high processing demands: An adult lifespan fMRI study of the aging brain. Neuroimage104, 21–34.
77.
OkamuraN, SuemotoT, FurumotoS, SuzukiM, ShimadzuH, AkatsuH, YamamotoT, FujiwaraH, NemotoM, MaruyamaM, AraiH, YanaiK, SawadaT, KudoY (2005) Quinoline and benzimidazole derivatives: Candidate probes for in vivo imaging of tau pathology in Alzheimer’s disease. J Neurosci25, 10857–10862.
ResnickSM, SojkovaJ, ZhouY, AnY, YeW, HoltDP, DannalsRF, MathisCA, KlunkWE, FerrucciL, KrautMA, WongDF (2010) Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C] PiB. Neurology74, 807–815.
80.
JackCRJr, WisteHJ, VemuriP, WeigandSD, SenjemML, ZengG, BernsteinMA, GunterJL, PankratzVS, AisenPS, WeinerMW, PetersenRC, ShawLM, TrojanowskiJQ, KnopmanDS, Alzheimer’s Disease Neuroimaging Initiative (2010) Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease. Brain133, 3336–3348.
81.
YarkoniT, PoldrackRA, NicholsTE, Van EssenDC, WagerTD (2011) Large-scale automated synthesis of human functional neuroimaging data. Nat Methods8, 665–670.
82.
McDonoughIM, WongJT, GalloDA (2012) Age-related differences in prefrontal cortex activity during retrieval monitoring: Testing the compensation and dysfunction accounts. Cereb Cortex23, 1049–1060.
83.
McDonoughIM, CervantesSN, GraySJ, GalloDA (2014) Memory’s aging echo: Age-related decline in neural reactivation of perceptual details during recollection. Neuroimage98, 346–358.
84.
LealSL, YassaMA (2013) Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer’s disease. Ageing Res Rev12, 823–831.
85.
SperlingRA, DickersonBC, PihlajamakiM, VanniniP, LaViolettePS, VitoloOV, HeddenT, BeckerJA, RentzDM, SelkoeDJ, JohnsonKA (2010) Functional alterations in memory networks in early Alzheimer’s disease. Neuromolecular Med12, 27–43.
86.
RodrigueKM, KennedyKM, DevousMD, RieckJR, HebrankAC, Diaz-ArrastiaR, MathewsD, ParkDC (2012) β-Amyloid burden in healthy aging: Regional distribution and cognitive consequences. Neurology78, 387–395.
87.
MoscovitchM, CabezaR, WinocurG, NadelL (2016) Episodic memory and beyond: The hippocampus and neocortex in transformation. Annu Rev Psychol67, 105–134.
88.
KoenJD, YonelinasAP (2014) The effects of healthy aging, amnestic mild cognitive impairment, and Alzheimer’s disease on recollection and familiarity: A meta-analytic review. Neuropsychol Rev24, 332–354.
89.
SchoemakerD, GauthierS, PruessnerJC (2014) Recollection and familiarity in aging individuals with mild cognitive impairment and Alzheimer’s disease: A literature review. Neuropsychol Rev24, 313–331.
90.
McEwenBS, StellarE (1993) Stress and the individual: Mechanisms leading to disease. Arch Intern Med153, 2093–2101.
91.
CabezaR, AlbertM, BellevilleS, CraikFI, DuarteA, GradyCL, LindenbergerU, NybergL, ParkDC, Reuter-LorenzPA, RuggMD, SteffenerJ, RajahMN (2018) Maintenance, reserve and compensation: The cognitive neuroscience of healthy ageing. Nat Rev Neurosci19, 701–710.
92.
Solé-PadullésC, Bartrés-FazD, JunquéC, VendrellP, RamiL, ClementeIC, BoschB, VillarA, BargallóN, JuradoMA, BarriosM, MolinuevoJL (2009) Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging30, 1114–1124.
93.
McDonoughIM, HaberS, BischofGN, ParkDC (2015) The Synapse Project: Engagement in mentally challenging activities enhances neural efficiency. Restor Neurol Neurosci33, 865–882.
